Mirae Asset Global Etfs Holdings Ltd. Igm Biosciences, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 9,096 shares of IGMS stock, worth $11,279. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,096
Previous 8,706
4.48%
Holding current value
$11,279
Previous $53,000
81.13%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IGMS
# of Institutions
82Shares Held
16.2MCall Options Held
26.8KPut Options Held
800-
Baker Bros. Advisors LP New York, NY4.1MShares$5.08 Million0.06% of portfolio
-
Siren, L.L.C. New York, NY3.26MShares$4.04 Million0.21% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$3.66 Million0.36% of portfolio
-
Black Rock Inc. New York, NY883KShares$1.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA876KShares$1.09 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $35.9M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...